Business
Viveve(R) Announces Asia Pacific Distribution Partnership to Purchase a Minimum of 231 Systems
Viveve(R) Announces Asia Pacific Distribution Partnership to Purchase a Minimum of 231 Systems.
About this update from Viveve Medical, Inc.
[{"type":"text","content":"\nViveve(R) Announces Asia Pacific Distribution Partnership to Purchase a Minimum of 231 Systems \n\nViveve(R) Announces Asia Pacific Distribution Partnership to Purchase a Minimum of 231 Systems\n\n\nViveve Treatment Now Available in 50 Countries Throughout the World\n\n\n SUNNYVALE, CA--(Marketwired - January 26, 2016) - Viveve Medical, Inc. (\"Viveve\") (OTCQB: VIVMF), a company focused on women's health, today announced the expansion of its commercial partnership with Dynamic Medical Technologies, Inc. (\"DMT\") a specialized and distinguished supplier of medical devices headquartered in Taipei, Taiwan into certain Asian Pacific countries. This exclusive, 3 year distribution partnership expands Viveve's global presence and includes minimum purchase requirements of 47 Viveve Systems in 2016, 75 in 2017 and 109 in 2018. \"We are thrilled about our expanded partnership with DMT, which also has distribution rights in Taiwan. We believe it will solidify Viveve as the premier product for the treatment of vaginal laxity in the Asia Pacific region and greatly increase the availability of the Viveve Treatment,\" said Patricia Scheller, the Chief Executive Officer of Viveve. \"The clinically demonstrated safety and efficacy profile of this painless procedure makes the Viveve Treatment the best alternative for treating a condition that can profoundly impact a woman's sexual satisfaction and quality of life.\" \"Our commitment is to provide physicians and medical professionals with high quality, clinically-proven products that fulfill their needs and deliver exceptional marketing, training and maintenance service,\" said Justin Jen, Vice President of DMT. \"We offer only what we believe are the best technologies -- those that provide us with evidence of safety and optimal results. The Viveve System is in precise alignment with our goal of bringing innovative technologies to our physicians and their patients. Now women who have this very common and frustrating condition will have access to a safe and proven procedure that is aimed at improving vaginal laxity and restoring sexual satisfaction.\"Viveve now has 16 exclusive distribution partnerships covering 50 countries throughout the world with regulatory clearance in 22 of those countries:\n \n \n GEOGRAPHICREGION\n \n \n DISTRIBUTIONCOVERAGE\n \n ...